Acute Myeloid Leukemia

48 total trials 23 recruiting

Filter these 48 trials by phase, country, sponsor and more.

Open in Search →

Venetoclax in children with relapsed AML Recruiting

2023-510160-12-00 5 2022-08-16
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) Recruiting

2023-506546-23-00 5 2020-05-20
Wilms’ tumor (WT1) antigen-targeted dendritic cell vaccination to prevent relapse in adult patients with acute myeloid leukemia: a multicent … Recruitment ended

2024-515292-35-00 4 2026-01-09
A multicenter, open-label, randomized, phase 2 study of venetoclax and azacitidine plus cusatuzumab versus venetoclax and azacitidine alone … Recruitment ended

2024-510991-19-00 4 2024-08-14
STUDY AGORA-1 / ALFA 2100: Phase 2 on the combinaison of Gemtuzumab Ozogamicin witk gilteritinib in adult patients with acute myeloid leukem … Recruitment ended

2023-504176-25-00 9 2024-08-08
CA-4948-104: A Ph1 Study of Emavusertib in AML CR MRD+ Patients Currently Receiving Azacitidine and Venetoclax Recruitment ended

2023-505828-58-00 3 2023-12-05
A Phase 1b Study of Bleximenib in Combination with AML Directed Therapies for Participants with Acute Myeloid Leukemia Harboring KMT2A or NP … Recruitment ended

2023-506582-58-00 3 2022-07-21
An Open-label, Multicenter, Phase 1b Study of OV-1001 (Cusatuzumab; Anti-CD70 Monoclonal Antibody) in Combination with Background Therapy fo … Recruitment ended

2024-513276-17-00 3 2020-07-01
A randomized phase II multicenter study to assess the tolerability and efficacy of the addition of midostaurin to 10-day decitabine in unfit … Recruitment ended

2023-503829-18-00 4 2019-12-05
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio … Recruitment ended

2022-502832-37-00 5 2019-03-01
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood Recruitment ended

2023-510009-16-00 9 2018-12-04
Study to determine safety, efficacy and tolerability of Venetoclax in combination with Fludarabine, Citarabine and Idarubicin to achieve "th … Recruitment ended

2023-510517-26-00 9 2018-10-26
A Phase 1/2 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Daily Intravenous of AB8939 in patients with Relapsed/Refractory A … Halted

2024-516641-39-00 7 2024-12-02
VEN-R DASA-IPC 2022-067 Evaluation of DASATINIB monotherapy efficacy in acute myeloid leukemia patients refractory to VENETOCLAX-AZACITIDINE Halted

2023-505846-24-00 4 2024-04-08
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Halted

2022-500783-35-00 5 2022-12-06
An open-label, single-arm, pilot study of Venetoclax in combination with 5 days Azacitidine in treatment-naïve subjects with acute myelogen … Ended

2022-501537-23-00 4 2023-05-16
Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia Ended

2023-507748-35-00 1 2022-11-08
A clinical study conducted to evaluate the safety, efficacy and tolerability of a drug called liposomal annamycin administered with cytarabi … Ended

2024-516388-10-00 9 2022-09-23
An Open-Label Phase I/II Study of Relatlimab (BMS-986016) with Nivolumab (BMS-936558) in Combination with 5-Azacytidine for Relapsed/Refract … Ended

2024-514948-89-00 9 2021-01-27
A Clinical Study to Compare the Effectiveness and Safety of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in … Ended

2024-515424-36-00 4 2020-10-15
MRD-guided treatment with pembrolizumab and azacitidine in NPM1mut AML patients with an imminent hematological relapse Ended

2024-513956-14-00 4 2019-09-16
A Clinical Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia who are not Candidates for Intensiv … Ended

2024-513283-26-00 4 2019-08-20
A Study of Venetoclax Co-Administered with Low Dose Cytarabine Versus Low Dose Cytarabine in Untreated Patients with Acute Myeloid Leukemia … Ended

2024-513630-37-00 5 2017-10-24
A Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in previously untreated Subjects with Acute Myeloid Leukemia who ar … Ended

2024-513631-25-00 5 2017-08-17

Showing 25–48 of 48 trials